Plain-English translation of NCT07354971 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is tracking people with advanced cancer who are receiving immune checkpoint inhibitors—a type of cancer therapy that helps the body's immune system fight the disease. Researchers want to understand how physical fitness, side effects, and quality of life change during this treatment, and whether fitness levels affect how well people tolerate the medication and respond to it.
While immune checkpoint inhibitors have become an important cancer treatment, doctors don't yet fully understand how this medication affects a person's physical fitness or whether fitness levels predict who will do better with treatment and have fewer side effects. This study aims to fill that gap so that exercise and fitness could eventually become part of cancer care.
You likely qualify if…
You likely don't qualify if…
Participants will visit the hospital to complete a supervised exercise fitness test and answer questions about their quality of life and side effects. They will be asked to visit regularly during their cancer treatment—likely every few weeks—to repeat these tests and assessments so researchers can track how fitness and well-being change over time. Some participants may also be asked to provide small tissue samples (biopsies) to help researchers understand immune changes during treatment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United Kingdom